1.Plasmacytoma of the pancreas: an unusual manifestation of multiple myeloma.
Susan Swee Shan HUE ; Rafay AZHAR
Singapore medical journal 2013;54(5):e105-7
Extramedullary plasmacytoma of the pancreas is a rare entity. Although this condition is uncommon, it should be considered in the differential diagnosis of solid mass in the pancreas, especially in patients with underlying multiple myeloma. We report a case of pancreatic plasmacytoma in a 56-year-old woman with newly diagnosed multiple myeloma. We highlight this rare manifestation of multiple myeloma among other better recognised presentations.
Diagnosis, Differential
;
Female
;
Humans
;
Immunohistochemistry
;
Keratins
;
metabolism
;
Middle Aged
;
Multiple Myeloma
;
diagnosis
;
pathology
;
Pancreas
;
pathology
;
Pancreatic Neoplasms
;
diagnosis
;
pathology
;
Plasmacytoma
;
diagnosis
;
pathology
;
Syndecan-1
;
metabolism
2.Relation of B7-H3 molecule expression in multiple myeloma with poor prognosis and bone destruction.
Dan-Dan ZHAO ; Liang LIN ; Qing GE ; Zhen-Yu LI ; Xu-Peng HE ; Kai-Lin XU ; Jin LU ; Xiao-Jun HUANG
Journal of Experimental Hematology 2013;21(3):637-642
This study was purpose to investigate the B7-H3 expression in multiple myeloma cell lines and CD138 cells of patients with multiple myeloma, and explore its clinical significance. Three myeloma cell lines (RPMI8226, U266 and H929) were used. Forty-five patients with multiple myeloma were enrolled in the study. The expression of B7-H3 was detected by flow cytometry and RT-PCR. The relationship between B7-H3 and clinical prognostic factor was analyzed. The results showed that (1)In myeloma cell lines, high expression of B7-H3 was seen in RPMI8226 (92.30 ± 1.1)% and U266 (79.03 ± 1.2)% but not in H929 cell line (4.26 ± 0.2)%. (2) Exogenous IL-6 had no effect on upregulation of B7-H3 in myeloma cell lines. (3) In multiple myeloma patients, the proportions of B7-H3 positive cells in newly diagnosed, remission and relapsed patients were (48.58 ± 33.593)%, (22.16 ± 18.853)%, and (57.65 ± 28.296)%, respectively. The difference between the newly diagnosed and remission patients, and remission and relapsed patients was significant (P = 0.023, P = 0.004). (4)High B7-H3 expression was correlated with high numbers of bone destruction and high levels of serum calcium (P = 0.027, P = 0.046, respectively). It is concluded that the relation of B7-H3 molecule expression with prognosis of multiple myeloma may be negative, but with degree of bone destruction is positive, thus the high expression of B7-H3 may correlated with disease progression and bone destruction of patients with multiple myeloma.
Adult
;
Aged
;
Aged, 80 and over
;
B7 Antigens
;
genetics
;
metabolism
;
Bone and Bones
;
pathology
;
Calcium
;
blood
;
Cell Line, Tumor
;
Female
;
Humans
;
Male
;
Middle Aged
;
Multiple Myeloma
;
diagnosis
;
metabolism
;
pathology
;
Prognosis
3.Diagnosis of hematolymphoid malignancy by using effusion fluid cytology specimens: a study of 33 cases.
Xue-ying SU ; Xia XU ; Yuan TANG ; Gan-di LI
Chinese Journal of Pathology 2009;38(8):542-546
OBJECTIVETo study the diagnostic accuracy of hematolymphoid malignancy by using effusion fluid cytology specimens and to evaluate the values of immunocytochemistry for this assay.
METHODSThe cytospin preparations/smears and cell block sections of effusion cytology specimens from 33 cases of hematolymphoid malignancy were retrospectively reviewed. Immunocytochemical study was performed. In selected cases, in-situ hybridization for Epstein-Barr virus-encoded RNA and immunoglobulin and T-cell receptor gene rearrangement study were carried out as indicated.
RESULTSThere were 33 cases of hematolymphoid malignancy, including 12 cases of T-lymphoblastic leukemia/lymphoma, 16 cases of mature B cell neoplasm (including 9 cases of diffuse large B-cell lymphoma, 2 cases of Burkitt lymphoma, 2 cases of plasmacytoma/multiple myeloma, 2 cases of B-small lymphocytic leukemia/lymphoma and 1 case of mantle cell lymphoma), 3 cases of mature T or NK-cell neoplasm (including 1 case of extranodal nasal NK/T-cell lymphoma, 1 case of angioimmunoblastic T-cell lymphoma and 1 case of T-cell prolymphocytic leukemia), 1 case of myeloid sarcoma and 1 case of mast cell sarcoma. Amongst the 33 cases studied, 16 represented disease relapses, including 8 cases of diffuse large B-cell lymphoma, 2 cases of plasmacytoma/multiple myeloma, 2 cases of B-small lymphocytic leukemia/lymphoma, 1 case of T-lymphoblastic leukemia/lymphoma, 1 case of angioimmunoblastic T-cell lymphoma, 1 case of mantle cell lymphoma and 1 case of mast cell sarcoma. The remaining 17 cases showed serous effusion as the primary manifestation, with the diagnosis primarily made upon cytologic examination. The cytologic findings seen in all the 33 cases studied were in agreement with the corresponding histologic diagnosis.
CONCLUSIONSDiagnosis of hematolymphoid malignancy by effusion fluid cytology specimens is possible, especially when coupled with the clinical history, immunophenotype, in-situ hybridization and gene rearrangement study findings. This is especially so for cases with disease relapses.
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Ascitic Fluid ; metabolism ; pathology ; Burkitt Lymphoma ; diagnosis ; metabolism ; pathology ; Child ; Cytodiagnosis ; methods ; Female ; Humans ; Immunohistochemistry ; Lymphoma, Extranodal NK-T-Cell ; diagnosis ; metabolism ; pathology ; Lymphoma, Large B-Cell, Diffuse ; diagnosis ; metabolism ; pathology ; Male ; Middle Aged ; Multiple Myeloma ; diagnosis ; metabolism ; pathology ; Plasmacytoma ; diagnosis ; metabolism ; pathology ; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma ; diagnosis ; pathology ; Retrospective Studies ; Young Adult
4.A Case of Acute Promyelocytic Leukemia Concomitant with Plasma Cell Myeloma.
Jinsook LIM ; Gye Cheol KWON ; Sun Hoe KOO ; Ik Chan SONG ; Jimyung KIM
Annals of Laboratory Medicine 2014;34(2):152-154
No abstract available.
Blood Cell Count
;
Bone Marrow Cells/metabolism/pathology
;
Humans
;
Leukemia, Promyelocytic, Acute/complications/*diagnosis/pathology
;
Magnetic Resonance Imaging
;
Male
;
Middle Aged
;
Multiple Myeloma/complications/*diagnosis/pathology
;
Paraproteinemias/diagnosis
;
Syndecan-1/metabolism
5.A Case of Salivary-Type Amylase-Producing Multiple Myeloma Presenting as Mediastinal Plasmacytoma and Myelomatous Pleural Effusion.
Soon Jung OK ; In Suk KIM ; Eun Yup LEE ; Jeong Eun KANG ; Sun Min LEE ; Moo Kon SONG
Annals of Laboratory Medicine 2014;34(6):463-465
No abstract available.
Aged
;
Amylases/blood/*metabolism/urine
;
Bone Marrow/pathology
;
Electrophoresis, Agar Gel
;
Gene Rearrangement
;
Humans
;
Immunohistochemistry
;
Isoenzymes/blood/metabolism/urine
;
Male
;
Multiple Myeloma/*diagnosis/metabolism/pathology
;
Plasmacytoma/pathology
;
Pleural Effusion, Malignant/pathology
6.Plasmablastic lymphoma: a clinicopathologic analysis of 11 cases with review of literature.
Fen LI ; Wenshuang DING ; Zhuo ZUO ; Ning GENG ; Huai YANG ; Xiulan LIU ; Jianchao WANG ; Wenqing YAO ; Weiping LIU
Chinese Journal of Pathology 2016;45(1):37-42
OBJECTIVETo investigate the clinicpathologic features and diagnosis of plasmablastic lymphoma (PBL).
METHODSEleven cases of PBL were collected and followed up, with review of the literature. HIV and EBV status and their relationships with the tumor were specially compared as well.
RESULTSIn the current cohort, 10 patients were serologically HIV negative; the male to female ratio was 8 to 3, and the median age was 57 years. Ten cases showed extranodal involvement and one case was nodal based. At presentation, five patients had mid-facial involvement, including sinonasal area (3 cases) and oral cavity (2 cases). Histologically, six were PBL of oral mucosa type, and five were PBL with plasmacytic differentiation. In all cases, the neoplastic cells expressed CD138 and MUM-1, and were negative for CD20 and CD3ε; the median Ki-67 index was 80%. Five cases were EBER1/2 in situ hybridization positive. IgH or/and Igκ gene rearrangement was detected in all five cases examined.
CONCLUSIONSMost patients were no congenital or acquired immunodeficiency in the retrospective study. Of the died patients, EBER1/2 in situ hybridization were negative and their disease staging were Ⅳ, The neoplastic cells were immunoblastic or plasmablastic, sometimes the plasmacytoid cell can be seen and the neoplastic cell had mature plasma cell phenotype, the pathologic diagnosis of the lymphoma is still controversial now. Differentiate with plasma cell neoplasm is difficult, it is necessary to accumulate more cases for advanced study and observation in the future.
Female ; Gene Rearrangement ; Humans ; In Situ Hybridization ; Male ; Middle Aged ; Multiple Myeloma ; Plasma Cells ; Plasmablastic Lymphoma ; diagnosis ; pathology ; RNA, Viral ; metabolism ; Retrospective Studies
7.A Case of Non-secretory Myeloma with Crystal-storing Histiocytosis.
Soon Ho PARK ; Jeong Yeal AHN ; Yiel Hea SEO ; Pil Hwan PARK ; Kyung Hee KIM ; Young Hee SONG ; Ji Hun JEONG ; Jae Hoon LEE
The Korean Journal of Laboratory Medicine 2010;30(6):580-584
Crystal-storing histiocytosis (CSH) is a rare event observed in association with lymphoproliferative diseases, and mainly occurrs in plasma cell dyscrasias. It is presumed to be an intra-lysosomal accumulation of the secreted paraproteins. Crystal formation can be seen inside histiocyte-like cells with phagocytosed crystalline inclusions in the bone marrow and extramedullary sites. CSH is a rare morphological entity with poor prognostic implications and may be confused with Gaucher or pseudo-Gaucher cells. Herein we report a case of non-secretory myeloma associated with CSH showing a poor clinical course. A 79-yr-old male presenting with dizziness was evaluated in hematology department for anemia. Laboratory tests revealed Hb of 4.9 g/dL and beta2-microglobulin of 21,000 ng/mL (reference range, 0-370). Presence of monoclonal protein was not detected on protein electrophoresis and immunofixation in serum and urine. However, serum free light chain assay showed an increased kappa-light chain level of 126 mg/L (reference range, 3.3-19.4) resulting in an increased kappa/lambda ratio. The bone marrow touch print showed numerous plasma cells and crystal-laden histiocytes and immunohistochemical stainings on bone marrow biopsy revealed positivity for CD38, CD56 and kappa in the plasma cells and CD68 and kappa in crystal-laden histiocytes.
Aged
;
Antigens, CD/metabolism
;
Antigens, CD38/metabolism
;
Antigens, Differentiation, Myelomonocytic/metabolism
;
Bone Marrow Cells/pathology
;
Histiocytosis/complications/*diagnosis/radiography
;
Humans
;
Immunoglobulin kappa-Chains/analysis
;
Male
;
Multiple Myeloma/complications/*diagnosis/radiography
;
Tomography, X-Ray Computed
8.Solitary plasmacytoma of bone: a clinicopathologic, immunohistochemical and immunoglobulin gene rearrangement study.
Zhuo ZUO ; Wei-ping LIU ; Yuan TANG ; Cheng-feng BI ; Xiao-qing WANG ; Wen-yan ZHANG ; Qun-pei YANG ; Li-qun ZOU
Chinese Journal of Pathology 2010;39(3):177-182
OBJECTIVETo investigate clinicopathologic features of solitary plasmacytoma of bone (SPB) and the role of immuno-phenotype and immunoglobulin gene rearrangement detection in the diagnosis and differential diagnosis of SPB.
METHODSA total of 21 cases of SPB were selected during a period from 1990 to 2008. A retrospective clinicopathologic study and immunohistochemistry (EnVision or EliVision methods) of 17 antigens were performed. In addition, universal IgH (FR3A/LJH/VLJH) primers and BIOMED-2 PCR multiplex tubes were used for IgK and IgL rearrangement analysis.
RESULTSThe age of patients ranged from 36 to 72 years with a media of 50 years. Axial skeleton was the most common site of involvement, accounting for 66.7% of the cases (14 of 21), followed by the extremities of 33.3% (7 cases). Low serum level of M-components was found in 5 cases, including two of IgG type (21.4 g/L) and three of IgA type. Clinical manifestations were closely related to the anatomic sites involved, such as pain due to bone destruction, symptoms and signs caused by compression of spinal cord or nerve root, and pathological fracture. All cases presented as a solitary osteolytic lesion. According to the histological grading criteria, grade I tumor was seen in 12 of 21 cases (57.1%). The remaining were grade II (5 cases, 23.8%) and grade III (4 cases, 19.0%). Immunohistochemically, the neoplastic cells expressed two or more plasma cell antigens, including CD138, CD38 and PC, but no CD19 and CD20. CD79a expression detected in 23.8%(5/21) of the cases. Expression of CD56, CD27 and CD44v6 were 57.1% (12/21), 15.0% (3/20) and 23.8% (5/21), respectively. Follow-up data were available in 12 of the 21 patients (57.1%). Five patients were alive and 7 died. Three patients developed multiple myeloma (MM) and died of the tumor.
CONCLUSIONSSPB is a rare tumor with bone pain as the most common presenting symptom due to bone destruction. The diagnosis of EMP can only be established after exclusion of an extramedullay invasion by MM. Immunophenotype and IgH gene rearrangement analysis play important roles in the diagnosis of SPB.
ADP-ribosyl Cyclase 1 ; metabolism ; Adult ; Aged ; Bone Neoplasms ; genetics ; metabolism ; pathology ; surgery ; Diagnosis, Differential ; Female ; Follow-Up Studies ; Gene Rearrangement, B-Lymphocyte, Heavy Chain ; Humans ; Immunophenotyping ; Lymphoma, Large B-Cell, Diffuse ; metabolism ; pathology ; Lymphoma, Large-Cell, Anaplastic ; metabolism ; pathology ; Male ; Melanoma ; metabolism ; pathology ; Middle Aged ; Multiple Myeloma ; pathology ; Plasmacytoma ; genetics ; metabolism ; pathology ; surgery ; Retrospective Studies ; Survival Rate ; Syndecan-1 ; metabolism
9.Pyrosequencing as a Fast and Reliable Method in Detecting the MYD88 p.L265P Mutation in Decalcified Formalin-Fixed and Paraffin-Embedded Tissues.
Niklas GEBAUER ; Veronica BERNARD ; Claudia ROHNER ; Manuela KROKOWSKI ; Hartmut MERZ ; Alfred C FELLER ; Christoph THORNS
Annals of Laboratory Medicine 2014;34(2):170-173
No abstract available.
Adult
;
Aged
;
Base Sequence
;
Bone Marrow/metabolism/pathology
;
Female
;
Formaldehyde/chemistry
;
Gene Frequency
;
Humans
;
Male
;
Middle Aged
;
Multiple Myeloma/diagnosis/genetics
;
Mutation
;
Myeloid Differentiation Factor 88/chemistry/*genetics/metabolism
;
Paraffin Embedding
;
Sequence Analysis, DNA/*methods
;
Waldenstrom Macroglobulinemia/diagnosis/genetics
10.Expression of midkine and vascular endothelial growth factor in bone marrow of patients with multiple myeloma and its significance.
Journal of Experimental Hematology 2009;17(6):1464-1467
The purpose of this study was to explore the expressions of midkine (MK) and vascular endothelial growth factor (VEGF) in multiple myeloma (MM), and to evaluate their relation with angiogenesis and prognosis. The expression levels of MK and VEGF in bone marrow mononuclear cells of 31 MM patients in different stages and 20 controls were detected by real-time fluorescent quantitative RT-PCR. The results showed that the MM patients had significantly higher MK and VEGF expression level than control group (p < 0.05, p < 0.01), and there was a linear relationship between MK and VEGF (r = 0.692, p < 0.01); The expression levels of MK and VEGF in stage III was significantly higher than those in stage I and stage II (p < 0.05, p < 0.01), but there was no difference between stage I and stage II (p > 0.05); MK and VEGF levels were significantly decreased in MM patients after treatment than those before treatment (p < 0.05, p < 0.01). It is concluded that the high expression of MK and VEGF is correlated with angiogenesis and prognosis of MM, and there is synergistic effect between MK and VEGF. It is supposed that the monitoring MK and VEGF expression levels may contribute to guide the treatment and estimate prognosis for MM.
Adolescent
;
Adult
;
Aged
;
Bone Marrow
;
Case-Control Studies
;
Female
;
Humans
;
Male
;
Middle Aged
;
Multiple Myeloma
;
diagnosis
;
metabolism
;
pathology
;
Neoplasm Staging
;
Nerve Growth Factors
;
metabolism
;
Prognosis
;
Vascular Endothelial Growth Factor A
;
metabolism
;
Young Adult